Skip to main content

Christopher Stevo

Head of Investor Relations

Pfizer Inc (PFE)

Equibles does not estimate personal net worth.

Get an email with a short summary when Teva Pharmaceutical Industries Ltd publishes a filing, an earnings call transcript or a press release.

Get TEVA alerts

About Christopher Stevo

Christopher Stevo is recorded as Head of Investor Relations at Teva Pharmaceutical Industries Ltd (TEVA) and Head of Investor Relations at Pfizer Inc (PFE). Christopher Stevo has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Teva Pharmaceutical Industries Ltd on November 3, 2026. Teva Pharmaceutical Industries Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Pfizer Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Teva Pharmaceutical Industries Ltd includes Richard Francis (CEO and Board Member), Eli Kalif (CFO), Amir Weiss (Chief Accounting Officer) and 7 others.

Christopher Stevo on recent calls

“As usual, our materials are posted to our website this morning, so please feel free to see them there. And before I turn the call over to our CEO, Richard Francis, I'd like to remind everyone that we'll be making forward-looking statements on this call.”
Head of Investor Relations, Q3 2026 Teva Pharmaceutical Industries Ltd. Earnings Conference Call ·
“Thank you for joining us on our second quarter call. um obviously our materials are posted to our website this morning so please see those and before i turn the call over to our ceo richard francis i'd like to remind everyone that we'll be making forward-looking statements on this call the company cautions investors…”
Head of Investor Relations, Q2 2026 Teva Pharmaceutical Industries Ltd. Earnings Conference Call ·
“We'll be making forward-looking statements in the course of this call. Any statements we make are only as of today, and we do not undertake any obligation to update these statements beyond this call.”
Head of Investor Relations, Duvakitug (Anti-TL1A) Phase 2b additional data presentation after ECCO – Conference call ·

Affiliation history

Company network

Current role

Drug Manufacturers - General · Healthcare

Head of Investor Relations

Leadership on record at Teva Pharmaceutical Industries Ltd

Leadership on record at Pfizer Inc

Recent activity